Eads & Heald Wealth Management Bristol Myers Squibb CO Transaction History

Eads & Heald Wealth Management

$211 Million
Q3 2024

A detailed history of Eads & Heald Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eads & Heald Wealth Management holds 18,818 shares of BMY stock, worth $1.07 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

18,818

Previous 17,148 9.74%

Holding current value

$1.07 Million

Previous $712,000 36.8%

% of portfolio

0.46%

Previous 0.35%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$39.66 - $51.75 $66,232 - $86,422	1,670 Added 9.74%	18,818 $974,000
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $136,165 - $179,265	-3,383 Reduced 16.48%	17,148 $712,000
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $180,164 - $204,272	-3,755 Reduced 15.46%	20,531 $1.11 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $113,734 - $135,716	-2,346 Reduced 8.81%	24,286 $1.25 Million
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $29,581 - $33,077	-511 Reduced 1.88%	26,632 $1.55 Million
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $118,373 - $131,434	-1,858 Reduced 6.41%	27,143 $1.74 Million
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $17,018 - $19,303	-259 Reduced 0.89%	29,001 $2.01 Million
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $220,094 - $260,623	3,214 Added 12.34%	29,260 $2.11 Million
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $28 - $16,904	220 Added 0.85%	26,046 $1.85 Million
Q2 2022 Jul 26, 2022	BUY	$72.62 - $79.98 $19,026 - $20,954	262 Added 1.02%	25,826 $1.99 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $28,219 - $33,837	459 Added 1.83%	25,564 $1.87 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $6,703 - $7,815	125 Added 0.5%	25,105 $1.57 Million
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $52,365 - $61,339	885 Added 3.67%	24,980 $1.48 Million
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $23,773 - $25,889	384 Added 1.62%	24,095 $1.61 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $5,755 - $6,473	97 Added 0.41%	23,711 $1.5 Million
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $572,087 - $648,280	9,908 Added 72.29%	23,614 $1.46 Million
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $22,110 - $24,501	-385 Reduced 2.73%	13,706 $826,000
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $9,922 - $11,600	181 Added 1.3%	14,091 $828,000
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $10,904 - $15,846	235 Added 1.72%	13,910 $775,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $156,487 - $204,124	3,180 Added 30.3%	13,675 $877,000
Q3 2019 Oct 31, 2019	BUY	$42.77 - $50.71 $448,871 - $532,201	10,495 New	10,495 $532,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Account

Eads & Heald Wealth Management Bristol Myers Squibb CO Transaction History